PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites News-Medical.net People with ascites are also often candidates for liver transplantation. Elijah Bolotin , PhD, President of PharmaIN, said, "Orphan-drug designation by the FDA indicates the importance of this new drug candidate to a desperately ill group of patients ... |
